Cytotoxic T lymphocytes against the antigen‐processing‐defective RMA‐S tumor cell line
- 1 June 1992
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (6), 1639-1642
- https://doi.org/10.1002/eji.1830220644
Abstract
RMA‐S is an antigen processing‐defective cell line, obtained from a Rauscher virus‐induced tumor. The cells express only a low level of cell surface major histocompatibility complex (MHC) class I molecules, which are supposed to be devoid of internally derived antigenic peptides. We investigated Rauscher virus expression and Rauscher peptide presentation to virus‐specific cytotoxic T lymphocytes (CTL) by this cell line. Viral proteins are expressed properly, both intracellularly and atthe cell surface of RMA‐S. Rauscher peptides are presented tovirus‐specific CTL in the groove of both the class I H2Kb and Db molecules, but at a low level. Culture of RMA‐S cells at room temperature increases theirsusceptibility to CTL. The RMA‐S defect thus affects, but not totally abrogates, Rauscher peptide presentation by MHC class I molecules via the endogenous pathway. Thisindicates that the RMA‐S antigen processing deficit is not absolute.Keywords
This publication has 25 references indexed in Scilit:
- RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1992
- Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporterNature, 1991
- Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cellsEuropean Journal of Immunology, 1991
- Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.The Journal of Experimental Medicine, 1991
- Empty MHC class I molecules come out in the coldNature, 1990
- Association of class I major histocompatibility heavy and light chains induced by viral peptidesNature, 1989
- Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.The Journal of Experimental Medicine, 1988
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963